Gainers

  • NuCana NCNA stock rose 17.3% to $0.84 during Friday's after-market session. This security traded at a volume of 164.1K shares come close, making up 395.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $44.0 million.
  • Neuronetics STIM stock rose 10.22% to $1.94. The market value of their outstanding shares is at $56.0 million. As per the press release, Q2 earnings came out 3 days ago.
  • AIM ImmunoTech AIM stock rose 9.49% to $0.64. The company's market cap stands at $30.9 million.
  • Baudax Bio BXRX shares moved upwards by 8.38% to $0.63. The market value of their outstanding shares is at $4.5 million.
  • Nemaura Medical NMRD stock increased by 8.1% to $0.88. The market value of their outstanding shares is at $25.4 million.
  • Virax Biolabs Group VRAX shares rose 8.1% to $0.4. The market value of their outstanding shares is at $7.1 million.

Losers

  • PHAXIAM Therapeutics PHXM stock declined by 8.9% to $0.51 during Friday's after-market session. At the close, PHAXIAM Therapeutics's trading volume reached 67.5K shares. This is 30.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $31.1 million.
  • Synlogic SYBX stock decreased by 8.3% to $0.49. The company's market cap stands at $33.0 million. As per the press release, Q2 earnings came out yesterday.
  • Aveanna Healthcare Hldgs AVAH stock decreased by 8.16% to $1.69. The company's market cap stands at $314.1 million. The company's, Q2 earnings came out yesterday.
  • Syros Pharmaceuticals SYRS shares decreased by 8.12% to $3.51. The market value of their outstanding shares is at $72.6 million. As per the press release, Q2 earnings came out 3 days ago.
  • China Pharma Holding CPHI shares fell 7.21% to $0.23. The company's market cap stands at $2.2 million.
  • SAB Biotherapeutics SABS stock fell 5.43% to $0.76. The market value of their outstanding shares is at $39.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!